EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hematologic malignancies in Li–Fraumeni syndrome

A. N. Kazakova, A. B. Itov

Pediatric Hematology/Oncology and Immunopathology · 14.04.2026 · 25 (1) · 203-212

DOI: 10.24287/j.1088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Hematology/Oncology and Immunopathology, online erschienen am 14.04.2026. Verfasst von A. N. Kazakova und 1 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Li–Fraumeni Syndrome (LFS) is a rare, autosomal dominant, highly penetrant cancer predisposition syndrome caused by germline mutations in the TP53 (Tumor Protein 53) gene. The classic tumor spectrum of LFS includes adrenocortical carcinomas, breast cancer, central nervous system tumors, osteosarcomas, and soft tissue sarcomas. Hematologic malignancies (HMs) occur in 4–12% of LFS cases, with a predominance of acute lymphoblastic leukemia characterized by a specific cytogenetic variant – a hypodiploid karyotype. Myelodysplastic syndromes and acute myeloid leukemias are less common and are typically secondary to prior cytotoxic therapy. Given the unfavorable prognosis of HMs in LFS and the necessity of bone marrow transplantation as a curative treatment modality, early identification of this patient group and the selection of an optimal donor who does not carry germline TP53 mutations are of high importance. This review presents the fundamental principles of the pathogenetic basis of LFS and clinical screening criteria, providing a detailed description of the spectrum of HMs in LFS, with specific focus on the clinical and laboratory features of the most common variants.

Zitieren

APA

Kazakova, A. N., & Itov, A. B. (2026). Hematologic malignancies in Li–Fraumeni syndrome. Pediatric Hematology/Oncology and Immunopathology, 25(1), 203-212. https://doi.org/10.24287/j.1088

Vancouver

Kazakova AN, Itov AB. Hematologic malignancies in Li–Fraumeni syndrome. Pediatric Hematology/Oncology and Immunopathology. 2026;25(1):203-212. doi:10.24287/j.1088

BibTeX
@article{Kazakova2026,
  author = {Kazakova, A. N. and Itov, A. B.},
  title = {Hematologic malignancies in Li–Fraumeni syndrome},
  journal = {Pediatric Hematology/Oncology and Immunopathology},
  year = {2026},
  volume = {25},
  number = {1},
  pages = {203--212},
  doi = {10.24287/j.1088}
}
Kostenlos starten →